Table 1.
Individual and Overall
| Characteristic | Cases | Controls |
|---|---|---|
| Age1(yrs) | ||
| < 50 | 3 | 3 |
| > 50 | 13 | 13 |
| Median | 56 | 56 |
| Range | 44-75 | 43-73 |
| Obstime2 (months) | ||
| < 50 | 11 | 12 |
| ≥ 50 | 5 | 4 |
| Median | 44 | 44 |
| Range | 38-56 | 37-56 |
| Stage | ||
| II | 13 | 13 |
| III | 3 | 3 |
| Surgery3 | ||
| MRM | 12 | 12 |
| BCS | 4 | 4 |
| Chemo4 | ||
| FEC | 11 | 11 |
| other | 1 | 1 |
| No | 4 | 4 |
| Number of Cycles | ||
| 6 | 11 | 11 |
| 4 | 1 | 1 |
| Tamoxifen | ||
| yes | 15 | 15 |
| No | 1 | 1 |
| RT (Gy) | ||
| 50 Gy | 13 | 13 |
| 50+10 Gy | 3 | 3 |
Radiotherapy, surgical and chemotherapy treatment characteristics for cases (group A) and controls (group B).
1Age: Age at follow-up
2Obstime: observation time from breast cancer diagnosis to the outpatient examination
3Surgery: MRM = Radical mastectomy, BCS = breast conserving surgery
4Chemotherapy: FEC = (5Fluoro-Uracil, epirubicin, cyclophosfamide), FEC- regimen
Other = 4 cycles of epirubicin
No = no chemotherapy